We allocated 187 stock-compensation type stock options to two directors, with 18,700 shares underlying the targeted stock. The paid-in amount per option is 102,405 yen, and no cash payment is required due to the set-off method. The grant was executed as of September 15, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"8281","jir_company_name":"Xebio Holdings, Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-09-15","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/8281-20260915-01.pdf","jir_short_summary":"We allocated 187 stock-compensation type stock options to two directors, with 18,700 shares underlying the targeted stock. The paid-in amount per option is 102,405 yen, and no cash payment is required due to the set-off method. The grant was executed as of September 15, 2026.","jir_summary":"### Section Heading\nThis is a notice finalizing the allocation details of the stock-compensation type stock options based on the board resolution held on August 18, 2026. The grant date is September 15, 2026, and the targets are two directors with 187 options, each option covering 100 shares. Cash payment is not required under the set-off method pursuant to Corporate Law Article 246.\n\n### Section 2 Heading\nThis disclosure clarifies the grant date, total number, recipients, number of target shares, and payment method in the course of implementing the usual stock-compensation-based compensation system that requires shareholder approval. Going forward, the market will likely scrutinize the structure of executive compensation, and while the number of affected shares will be monitored for dilution purposes, the article text does not specify an exact dilution rate.","jir_financial_highlights":"Total number of stock options: 187 items (Unknown)\nTarget shares: 18,700 shares (Unknown)\nPaid-in amount for stock options: 102,405 yen per option (Unknown)","jir_category":"","jir_hashtags":"#XebioHoldings, #Stock-basedStockOptions","jir_key_figures":"Total number of stock options: 187 (each option corresponds to 100 shares)\nTarget shares: 18,700 shares\nPaid-in amount for stock options: 102,405 yen per option (1,024.05 yen per share)","jir_meta_title":"\u3010Xebio Holdings\u3011Content of Directors' Stock-based Stock Options Finalized\uff5c2026-09-15","jir_meta_description":"Xebio Holdings finalizes the allocation of stock-based stock options for two directors. Total: 187 options, target shares: 18,700, paid-in amount: 102,405 yen per option, cash payment not required due to set-off, grant date: 2026-09-15.","jir_og_title":"\u3010Xebio Holdings\u3011Content of Directors' Stock-based Stock Options Finalized","jir_og_description":"Xebio Holdings allocates 187 stock-based stock options to two directors. Total shares: 18,700, payment is via set-off with no cash payment required, grant date: 2026-09-15.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17366,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-114346","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n